Kai Health care Laboratory, a state-of-the-art diagnostics laboratory in Dallas, was acquired by Empower Clinics on Oct 6, 2020 to additional progress the Company’s COVID-19 nationwide screening systems for business clientele, including movie and tv studios, organizations and faculties
VANCOUVER, BC / ACCESSWIRE / November 13, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company”) an integrated health care enterprise serving a databases of 165,000 people by clinics in the southwest United States, a telemedicine system and health-related diagnostics laboratory, is happy to announce that Kai Medical Laboratory (“KAI”) has realized report screening volume for the month of October with 1,375 models processed.
File Accomplished IN PARTIAL Initial Thirty day period Beneath EMPOWER CLINICS
KAI testing quantity of 1,375 units in Oct signifies a sequential boost of 763% over testing quantity in September of 180 models. Furthermore, the boost arrives from only a partial thirty day period of handle less than Empower given the acquisition of KAI was only completed on October 6, 2020. Finally, provided the pretty recent closing of the acquisition, the record October results were realized without having the advantage of Empower’s prepared product sales, internet marketing and rollout options for KAI.
Empower Clinics Chairman and CEO, Steven McAuley, stated “The magnitude of KAI’s advancement and good results in October are unable to be overstated as an case in point of what is to appear. This is especially accurate given the truth we have but to thoroughly apply the profits and advertising and marketing procedures planned for KAI as we develop our nationwide testing courses for enterprise stage consumers throughout America. Although we are incredibly happy with the effects achieved in October, the testing volume of 1,375 models represents a portion of the lab’s capability which is able of achieving 4,000 COVID-19 RT-PCR assessments for each working day. It is our intention to continue on ramping up development significantly as a result of 2020 and perfectly into 2021.”
Development Tactics & Various NEW Industrial Tests CONTRACTS
The Firm is now operating via integration and utilizing aggressive development methods together with servicing new COVID-19 tests contracts for the movie & tv industry, banking companies, dining establishments, tourism and supporting the Sun Valley Wellness COVID-19 RT-PCR and swift antibody testing programs in the state of Arizona.
To this stop, on Oct 7th, Empower declared it experienced commenced COVID-19 RT-PCR checks for a main studio movie & tv production. On October 19th, Empower declared a partnership with Loop Insights to supply the to start with ever “travel bubble” alternative for the international travel market.
Last but not least, Empower has signed a lot of new business screening contracts, the aspects of which will be provided in subsequent press releases.
To even further aid with COVID-19 tests, Kai Professional medical Laboratory has also produced two important packages in Texas and Arizona. The very first method is a immediate-to-customer software that leverages the skill of several healthcare companies to get and administer both of those the RT-PCR test and the Antibody examination. This boosts the ability of the normal populace to be examined, in specific circumstances. The 2nd is an Employer COVID-19 Compliance Application (ECCP) for small business house owners and employer groups to allow them to exam and watch their workforce.
Texas system https://www.testtexasnow.com
Arizona method https://www.covidtest2u.com
The blend of all this commercial exercise considering that the Oct 6th acquisition supplies the Organization with the confidence required to aid the expectation of significantly further advancement in the months to arrive.
COVID-19 RT-PCR Screening IS THE GOLD Normal THAT Permits EMPOWER TO ROLL OUT Countrywide Section 4 Screening Courses
KAI Health-related Laboratory operates a large-complexity CLIA and COLA accredited laboratory that gives trusted and precise testing remedies to hospitals, healthcare clinics, pharmacies, and employer groups. KAI has taken an lively purpose in COVID-19 testing, battling the pandemic by means of RT-PCR testing and serology testing with the potential to process 4,000 RT-PCR examination specimens for each day. Although the RT-PCR exam identifies if a individual has an energetic virus, the serology or antibody examination detects if a affected person has beforehand been uncovered to the virus. Both of these take a look at success are important to controlling outbreaks and the potential unfold of coronavirus.
As a consequence of this capability, Empower is now ready to grow period 4 of its COVID-19 screening rollout which was first announced on April 27, 2020 starting with screening in-clinic tests (Section 1) and culminating with a nationwide roll-out throughout the United States (Phase 4). Stage 4 will allow Empower to company company level clientele, together with film and television studios that have to have trusted, exact, speedy and mass batch screening capabilities in get to resume creation in a safe and compliant fashion.
The Firm has also granted an mixture of 1,079,666 stock selections (every single, an “Option”) to particular important staff of the Firm in accordance with the Company’s inventory alternative program priced at $.05 CAD and 1,500,000 Options priced at $.08 CAD to an investor relations assistance service provider.
This push release is readily available on the Empower Clinics Confirmed Discussion board on AGORACOM for shareholder dialogue, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Empower is generating a community of medical professionals and practitioners who combine to provide client requires, in-clinic, by telemedicine, and with decentralized cellular shipping and delivery. A simplified, streamlined care model bringing vital characteristics of the health care supply chain together, always targeted on client knowledge. The Company presents COVID-19 screening products and services to consumers and firms as aspect of a four-phased nationwide tests initiative in the United States. Empower recently obtained Kai Health care Laboratory, LLC as a wholly owned subsidiary with substantial-scale tests functionality.
ON BEHALF OF THE BOARD OF Directors:
Chief Govt Officer
Investors: Dustin Klein
Traders: Steven McAuley
DISCLAIMER FOR Ahead-Wanting STATEMENTS
This news launch has sure “forward-on the lookout statements” or “forward-searching information” (collectively “forward hunting statements”) in the this means of applicable Canadian securities legal guidelines. All statements, other than statements of historical simple fact, are ahead-looking statements and are dependent on expectations, estimates and projections as at the date of this news launch. Ahead-searching statements can often be discovered by text these types of as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other identical words and phrases, or data that sure activities or ailments “may” or “will” occur. Forward-wanting statements in this information release incorporate, but are not limited to, statements concerning: the predicted gains to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory the transaction phrases the anticipated variety of clinics and individuals subsequent the closing the future likely good results of Kai Clinical Laboratory, Sun Valley’s franchise product the anticipated day of closing of the acquisition and the event thereof and that the Enterprise will be positioned to be a marketplace-top company provider for sophisticated patient needs in 2020 and beyond. This kind of statements are only projections, are based on assumptions acknowledged to administration at this time, and are subject to hazards and uncertainties that may well bring about true success, efficiency or developments to vary materially from individuals contained in the ahead-on the lookout statements, which include: that the Kai Health care Laboratory acquisition may well not be done on the terms expected or at all that the Company’s merchandise may well not perform as anticipated that the Business may possibly not be in a position to broaden COVID-19 tests that legislative variations may possibly have an adverse effect on the Company’s business enterprise and product or service enhancement that the Momentum Wellness acquisition may possibly not be finished on the phrases expected or at all that the Corporation may not be ready to acquire enough financing to go after its enterprise program normal business enterprise, economic, aggressive, political and social uncertainties failure to obtain any important approvals in relationship with the proposed transaction and other components further than the Company’s command. No assurance can be supplied that any of the events anticipated by the forward-searching statements will happen or, if they do occur, what positive aspects the Organization will acquire from them. Viewers are cautioned not to area undue reliance on the forward-searching statements in this launch, which are experienced in their entirety by these cautionary statements. The Company is underneath no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-seeking statements in this release, no matter if as a outcome of new info, upcoming situations or normally, except as expressly essential by applicable laws.
Resource: Empower Clinics Inc.
Watch resource model on accesswire.com: